Mark Hamer1, Emmanuel Stamatakis. 1. Department of Epidemiology and Public Health, 1-19 Torrington Place, University College London, London WC1E 6BT, United Kingdom. m.hamer@ucl.ac.uk
Abstract
CONTEXT: Previous studies have identified an obese phenotype without the burden of adiposity-associated cardiometabolic risk factors, although the health effects remain unclear. OBJECTIVE: We examined the association between metabolically healthy obesity and risk of cardiovascular disease (CVD) and all-cause mortality. DESIGN AND SETTING: This was an observational study with prospective linkage to mortality records in community-dwelling adults from the general population in Scotland and England. PARTICIPANTS: A total of 22,203 men and women [aged 54.1 (SD 12.7 yr), 45.2% men] without known history of CVD at baseline. INTERVENTIONS: Based on blood pressure, high-density lipoprotein-cholesterol, diabetes diagnosis, waist circumference, and low-grade inflammation (C-reactive protein ≥ 3 mg/liter), participants were classified as metabolically healthy (0 or 1 metabolic abnormality) or unhealthy (two or more metabolic abnormalities). Obesity was defined as a body mass index of 30 kg/m(2) or greater. MAIN OUTCOME MEASURE: Study members were followed up, on average, more than 7.0 ± 3.0 yr for cause-specific mortality. Cox proportional hazards models were used to examine the association of metabolic health/obesity categories with mortality. RESULTS: There were 604 CVD and 1868 all-cause deaths, respectively. Compared with the metabolically healthy nonobese participants, their obese counterparts were not at elevated risk of CVD [hazard ratio (HR) 1.26, 95% confidence interval (CI) 0.74-2.13], although both nonobese (HR 1.59, 95% CI 1.30-1.94) and obese (HR 1.64, 95% CI 1.17-2.30) participants with two or more metabolic abnormalities were at elevated risk. Metabolically unhealthy obese participants were at elevated risk of all-cause mortality compared with their metabolically healthy obese counterparts (HR 1.72, 95% CI 1.23-2.41). CONCLUSION: Metabolically healthy obese participants were not at increased risk of CVD and all-cause mortality over 7 yr.
CONTEXT: Previous studies have identified an obese phenotype without the burden of adiposity-associated cardiometabolic risk factors, although the health effects remain unclear. OBJECTIVE: We examined the association between metabolically healthy obesity and risk of cardiovascular disease (CVD) and all-cause mortality. DESIGN AND SETTING: This was an observational study with prospective linkage to mortality records in community-dwelling adults from the general population in Scotland and England. PARTICIPANTS: A total of 22,203 men and women [aged 54.1 (SD 12.7 yr), 45.2% men] without known history of CVD at baseline. INTERVENTIONS: Based on blood pressure, high-density lipoprotein-cholesterol, diabetes diagnosis, waist circumference, and low-grade inflammation (C-reactive protein ≥ 3 mg/liter), participants were classified as metabolically healthy (0 or 1 metabolic abnormality) or unhealthy (two or more metabolic abnormalities). Obesity was defined as a body mass index of 30 kg/m(2) or greater. MAIN OUTCOME MEASURE: Study members were followed up, on average, more than 7.0 ± 3.0 yr for cause-specific mortality. Cox proportional hazards models were used to examine the association of metabolic health/obesity categories with mortality. RESULTS: There were 604 CVD and 1868 all-cause deaths, respectively. Compared with the metabolically healthy nonobese participants, their obese counterparts were not at elevated risk of CVD [hazard ratio (HR) 1.26, 95% confidence interval (CI) 0.74-2.13], although both nonobese (HR 1.59, 95% CI 1.30-1.94) and obese (HR 1.64, 95% CI 1.17-2.30) participants with two or more metabolic abnormalities were at elevated risk. Metabolically unhealthy obese participants were at elevated risk of all-cause mortality compared with their metabolically healthy obese counterparts (HR 1.72, 95% CI 1.23-2.41). CONCLUSION: Metabolically healthy obese participants were not at increased risk of CVD and all-cause mortality over 7 yr.
Authors: James B Meigs; Peter W F Wilson; Caroline S Fox; Ramachandran S Vasan; David M Nathan; Lisa M Sullivan; Ralph B D'Agostino Journal: J Clin Endocrinol Metab Date: 2006-05-30 Impact factor: 5.958
Authors: Rachel P Wildman; Robert Kaplan; JoAnn E Manson; Aleksandar Rajkovic; Stephanie A Connelly; Rachel H Mackey; Lesley F Tinker; J David Curb; Charles B Eaton; Sylvia Wassertheil-Smoller Journal: Obesity (Silver Spring) Date: 2011-01-13 Impact factor: 5.002
Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone Journal: Circulation Date: 2004-07-13 Impact factor: 29.690
Authors: Kevin E Kip; Oscar C Marroquin; David E Kelley; B Delia Johnson; Sheryl F Kelsey; Leslee J Shaw; William J Rogers; Steven E Reis Journal: Circulation Date: 2004-02-17 Impact factor: 29.690
Authors: Alan J Flint; Frank B Hu; Robert J Glynn; Hervé Caspard; JoAnn E Manson; Walter C Willett; Eric B Rimm Journal: Obesity (Silver Spring) Date: 2009-07-30 Impact factor: 5.002
Authors: Yiqing Song; JoAnn E Manson; James B Meigs; Paul M Ridker; Julie E Buring; Simin Liu Journal: Am J Cardiol Date: 2007-12-01 Impact factor: 2.778
Authors: Tuomas O Kilpeläinen; M Carola Zillikens; Alena Stančákova; Francis M Finucane; Janina S Ried; Claudia Langenberg; Weihua Zhang; Jacques S Beckmann; Jian'an Luan; Liesbeth Vandenput; Unnur Styrkarsdottir; Yanhua Zhou; Albert Vernon Smith; Jing-Hua Zhao; Najaf Amin; Sailaja Vedantam; So-Youn Shin; Talin Haritunians; Mao Fu; Mary F Feitosa; Meena Kumari; Bjarni V Halldorsson; Emmi Tikkanen; Massimo Mangino; Caroline Hayward; Ci Song; Alice M Arnold; Yurii S Aulchenko; Ben A Oostra; Harry Campbell; L Adrienne Cupples; Kathryn E Davis; Angela Döring; Gudny Eiriksdottir; Karol Estrada; José Manuel Fernández-Real; Melissa Garcia; Christian Gieger; Nicole L Glazer; Candace Guiducci; Albert Hofman; Steve E Humphries; Bo Isomaa; Leonie C Jacobs; Antti Jula; David Karasik; Magnus K Karlsson; Kay-Tee Khaw; Lauren J Kim; Mika Kivimäki; Norman Klopp; Brigitte Kühnel; Johanna Kuusisto; Yongmei Liu; Osten Ljunggren; Mattias Lorentzon; Robert N Luben; Barbara McKnight; Dan Mellström; Braxton D Mitchell; Vincent Mooser; José Maria Moreno; Satu Männistö; Jeffery R O'Connell; Laura Pascoe; Leena Peltonen; Belén Peral; Markus Perola; Bruce M Psaty; Veikko Salomaa; David B Savage; Robert K Semple; Tatjana Skaric-Juric; Gunnar Sigurdsson; Kijoung S Song; Timothy D Spector; Ann-Christine Syvänen; Philippa J Talmud; Gudmar Thorleifsson; Unnur Thorsteinsdottir; André G Uitterlinden; Cornelia M van Duijn; Antonio Vidal-Puig; Sarah H Wild; Alan F Wright; Deborah J Clegg; Eric Schadt; James F Wilson; Igor Rudan; Samuli Ripatti; Ingrid B Borecki; Alan R Shuldiner; Erik Ingelsson; John-Olov Jansson; Robert C Kaplan; Vilmundur Gudnason; Tamara B Harris; Leif Groop; Douglas P Kiel; Fernando Rivadeneira; Mark Walker; Inês Barroso; Peter Vollenweider; Gérard Waeber; John C Chambers; Jaspal S Kooner; Nicole Soranzo; Joel N Hirschhorn; Kari Stefansson; H-Erich Wichmann; Claes Ohlsson; Stephen O'Rahilly; Nicholas J Wareham; Elizabeth K Speliotes; Caroline S Fox; Markku Laakso; Ruth J F Loos Journal: Nat Genet Date: 2011-06-26 Impact factor: 38.330
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2013-12-18 Impact factor: 29.690
Authors: D J Cuthbertson; T Steele; J P Wilding; J C Halford; J A Harrold; M Hamer; F Karpe Journal: Int J Obes (Lond) Date: 2017-01-12 Impact factor: 5.095
Authors: Angela K Green; Paul F Jacques; Gail Rogers; Caroline S Fox; James B Meigs; Nicola M McKeown Journal: Obesity (Silver Spring) Date: 2014-03-08 Impact factor: 5.002